About cspc pharmaceutical group ltd. - CSPCY
CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. It operates through the following business segments: Finished Drugs, Antibiotics, Vitamin C, Caffeine and Others. The company was founded on August 21, 1997 and is headquartered in Shijiazhuang, China.
CSPCY At a Glance
CSPC Pharmaceutical Group Ltd.
No.896 Zhongshandong Street
Shijiazhuang, Hebei 050035
| Phone | 86-311-8703-7015 | Revenue | 3.62B | |
| Industry | Biotechnology | Net Income | 540.05M | |
| Sector | Health Technology | Employees | 19,700 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
CSPCY Valuation
| P/E Current | 18.451 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 22.909 |
| Price to Sales Ratio | 3.42 |
| Price to Book Ratio | 2.614 |
| Price to Cash Flow Ratio | 14.69 |
| Enterprise Value to EBITDA | 15.21 |
| Enterprise Value to Sales | 3.149 |
| Total Debt to Enterprise Value | 0.008 |
CSPCY Efficiency
| Revenue/Employee | 183,641.892 |
| Income Per Employee | 27,413.605 |
| Receivables Turnover | 2.648 |
| Total Asset Turnover | 0.567 |
CSPCY Liquidity
| Current Ratio | 2.186 |
| Quick Ratio | 1.883 |
| Cash Ratio | 0.871 |
CSPCY Profitability
| Gross Margin | 65.595 |
| Operating Margin | 15.282 |
| Pretax Margin | 18.69 |
| Net Margin | 14.928 |
| Return on Assets | 8.462 |
| Return on Equity | 11.781 |
| Return on Total Capital | 11.159 |
| Return on Invested Capital | 11.738 |
CSPCY Capital Structure
| Total Debt to Total Equity | 1.932 |
| Total Debt to Total Capital | 1.896 |
| Total Debt to Total Assets | 1.373 |
| Long-Term Debt to Equity | 0.545 |
| Long-Term Debt to Total Capital | 0.534 |